Early R-CHOP therapy assessment using FLT PET/CT in patients with DLBCL treated with R-CHOP - the initial results

被引:0
|
作者
Malkowski, B. [1 ]
Chmielowska, E. [1 ]
Olejnik, M. [1 ]
Pietrzak, T. [1 ]
Makarewicz, A. [1 ]
Kachniarz, A. [1 ]
Kasprzak, K. [1 ]
机构
[1] Ctr Oncol, Bydgoszcz, Poland
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S250 / S251
页数:2
相关论文
共 50 条
  • [21] R-CHOP therapy for MALT lymphoma of the rectum
    Chihara, Dai
    Kagami, Yoshitoyo
    Oki, Yasuhiro
    Kato, Harumi
    Onoda, Hiroshi
    Ine, Shouji
    Taji, Hirofumi
    Yamamoto, Kazuhito
    Morishima, Yasuo
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (01) : 84 - 86
  • [22] Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
    Wilson, Wyndham H.
    Wright, George W.
    Huang, Da Wei
    Hodkinson, Brendan
    Balasubramanian, Sriram
    Fan, Yue
    Vermeulen, Jessica
    Shreeve, Martin
    Staudt, Louis M.
    CANCER CELL, 2021, 39 (12) : 1643 - +
  • [23] Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
    Bantilan, Kurt S.
    Smith, Alexandra N.
    Maurer, Matthew J.
    Teruya-Feldstein, Julie
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Straus, David J.
    Noy, Ariela
    Palomba, M. Lia
    Horwitz, Steven M.
    Hamlin, Paul A.
    Portlock, Carol S.
    Cerhan, James R.
    Habermann, Thomas M.
    Salles, Gilles A.
    Nowakowski, Grzegorz S.
    Moskowitz, Craig H.
    Zelenetz, Andrew D.
    BLOOD ADVANCES, 2024, 8 (09) : 2172 - 2181
  • [24] 80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL
    Takahashi, Anna
    Mishima, Yuko
    Inoue, Norihito
    Kusano, Yoshiharu
    Gunji, Tadahiro
    Ueda, Kyoko
    Nishimura, Noriko
    Nitta, Hideaki
    Yokoyama, Masahiro
    Tsuyama, Naoko
    Takeuchi, Kengo
    Terui, Yasuhito
    Hatake, Kiyohiko
    BLOOD, 2015, 126 (23)
  • [25] Bcl-6 protein not a prognostic indicator in patients with DLBCL receiving R-CHOP therapy
    Nature Clinical Practice Oncology, 2006, 3 (8): : 413 - 413
  • [26] CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies
    Ayed O. Ayed
    Annalisa Chiappella
    Levi Pederson
    Betsy R. Laplant
    Angela Giovanna Congiu
    Gianluca Gaidano
    Michele Spina
    Alessandro Re
    Federica Cavallo
    Gerardo Musuraca
    William R. Macon
    Thomas Witzig
    Umberto Vitolo
    Grzegorz S. Nowakowski
    Blood Cancer Journal, 8
  • [27] Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL
    Marshall, Shoko
    Nishimura, Noriko
    Inoue, Norihito
    Yamauchi, Hirofumi
    Tsuyama, Naoko
    Takeuchi, Kengo
    Mishima, Yuko
    Yokoyama, Masahiro
    Ogasawara, Toshie
    Mori, Naoki
    Ogawa, Tetsuya
    Sakura, Hiroshi
    Terui, Yasuhito
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (03): : 162 - 169
  • [28] DLBCL 1L-What to Expect beyond R-CHOP?
    Stegemann, Maike
    Denker, Sophy
    Schmitt, Clemens A.
    CANCERS, 2022, 14 (06)
  • [29] MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL.
    Johnson, Nathalie A.
    Ben-Neriah, Susanna
    Savage, Kerry J.
    Lee, Tang
    Horsman, Douglas E.
    Connors, Joseph M.
    Chan, Wing C.
    Lenz, Georg
    Wright, George
    Rimsza, Lisa M.
    Braziel, Rita M.
    Cook, James R.
    Tubbs, Raymond R.
    Weisenburger, Dennis D.
    Campo, Elias
    Rosenwald, Andreas
    Ott, German
    Delabie, Jan
    Jaffe, Elaine S.
    Staudt, Louis M.
    Gascoyne, Randy D.
    BLOOD, 2009, 114 (22) : 452 - 452
  • [30] Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP
    Bernard, Sophie
    Ghesquieres, Herve
    Casasnovas, Rene-Olivier
    Griolet, Samuel
    da Silva, Maria Gomes
    Feugier, Pierre
    Morschhauser, Franck
    Trotman, Judith
    Renaud, Loic
    Greil, Richard
    Martin Garcia-Sancho, Alejandro
    Grosicki, Sebastian
    van Eygen, Koen
    Copie-Bergman, Christiane
    Haioun, Corinne
    Thieblemont, Catherine
    BLOOD ADVANCES, 2021, 5 (15) : 2965 - 2968